Janney Montgomery Scott
RPRX icon

Janney Montgomery Scott’s Royalty Pharma RPRX Stock Holding History

Janney Montgomery Scott’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$446K Sell
7,961
-297
-4% -$15.5K ﹤0.01% 2470
2026
Q1 		$396K Sell
8,258
-149
-2% -$6.53K ﹤0.01% 2200
2025
Q4 		$325K Buy
8,407
+2,044
+32% +$77.9K ﹤0.01% 2504
2025
Q3 		$224K Buy
+6,363
New +$230K ﹤0.01% 2674
2023
Q4 		– Sell
-18,972
Closed -$515K – 2737
2023
Q3 		$515K Sell
18,972
-811
-4% -$24.1K ﹤0.01% 1746
2023
Q2 		$608K Buy
+19,783
New +$670K ﹤0.01% 1714
2022
Q2 		– Sell
-6,422
Closed -$250K – 2418
2022
Q1 		$250K Sell
6,422
-102
-2% -$4K ﹤0.01% 1977
2021
Q4 		$260K Buy
+6,524
New +$253K ﹤0.01% 2084

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janney Montgomery Scott's RPRX Position: Q2 2026 in Review

Janney Montgomery Scott reduced its Royalty Pharma (RPRX) stake by 3.6% in Q2 2026, selling an estimated $15.5K and leaving 7,961 shares worth $446K. The position accounts for ﹤0.01% of the portfolio, ranked #2470.

Janney Montgomery Scott first reported a position in RPRX in Q4 2021 and has held it in 8 quarters since. The position peaked at $608K in Q2 2023. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Janney Montgomery Scott held 7,961 shares of Royalty Pharma worth $446K as of Q2 2026.
  • Janney Montgomery Scott sold 297 Royalty Pharma shares in Q2 2026, an estimated $15.5K.
  • Royalty Pharma made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2470 holding.
  • Janney Montgomery Scott first reported a position in Royalty Pharma in Q4 2021 and has held it in 8 quarters since.
  • Janney Montgomery Scott's Royalty Pharma position peaked at $608K in Q2 2023.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.